199 related articles for article (PubMed ID: 8411729)
1. [Molecular biological analysis of neurofibromatosis type 2 gene].
Ichimura K; Yuasa Y
Nihon Rinsho; 1993 Sep; 51(9):2462-6. PubMed ID: 8411729
[TBL] [Abstract][Full Text] [Related]
2. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
4. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
Kley N; Seizinger BR
Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
[TBL] [Abstract][Full Text] [Related]
5. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
6. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
7. The tumour suppressor protein NF2/merlin: the puzzle continues.
Hovens CM; Kaye AH
J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
[TBL] [Abstract][Full Text] [Related]
8. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
9. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
10. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
11. Constitutional translocation t(4;22) (q12;q12.2) associated with neurofibromatosis type 2.
Arai E; Ikeuchi T; Karasawa S; Tamura A; Yamamoto K; Kida M; Ichimura K; Yuasa Y; Tonomura A
Am J Med Genet; 1992 Sep; 44(2):163-7. PubMed ID: 1456285
[TBL] [Abstract][Full Text] [Related]
12. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
Halum SL; Erbe CB; Friedland DR; Wackym PA
Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
[TBL] [Abstract][Full Text] [Related]
13. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.
Trofatter JA; MacCollin MM; Rutter JL; Murrell JR; Duyao MP; Parry DM; Eldridge R; Kley N; Menon AG; Pulaski K
Cell; 1993 Mar; 72(5):791-800. PubMed ID: 8453669
[TBL] [Abstract][Full Text] [Related]
14. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
[TBL] [Abstract][Full Text] [Related]
15. Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma.
Zirn B; Arning L; Bartels I; Shoukier M; Hoffjan S; Neubauer B; Hahn A
Clin Genet; 2012 Jan; 81(1):82-7. PubMed ID: 21175598
[TBL] [Abstract][Full Text] [Related]
16. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 2: a new mechanism of tumor suppression.
Lutchman M; Rouleau GA
Trends Neurosci; 1996 Sep; 19(9):373-7. PubMed ID: 8873351
[TBL] [Abstract][Full Text] [Related]
18. [Development and establishment of a yeast-based stop codon assay for detection of NF2 gene premature-terminating mutations].
Kobayashi H
Hokkaido Igaku Zasshi; 1999 Sep; 74(5):377-86. PubMed ID: 10495852
[TBL] [Abstract][Full Text] [Related]
19. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 2: molecular and clinical analyses in Argentine sporadic and familial cases.
Ferrer M; Schulze A; Gonzalez S; Ferreiro V; Ciavarelli P; Otero J; Giliberto F; Basso A; Szijan I
Neurosci Lett; 2010 Aug; 480(1):49-54. PubMed ID: 20553997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
